Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
88 results
D3.354 - Selective IgE deficiency in children: its role in autoimmunity
D3.356 - Unconventional T cells in leukocyte adhesion deficiency I (LAD-I)
D3.362 - Use and safety of canakinumab during pregnancy
D3.382 - Evaluation of Serum Arginase-1 Levels in Chronic Urticaria
D3.394 - Anxiety Associated with Parenteral On-Demand Treatment for Hereditary Angioedema Attacks in Patients from Italy
D3.57 - Isoniazid-Induced Lupus in a Filipino Female: A Case Report
D1.292 - Assessing Quality of Life in Chronic Spontaneous Urticaria: Insights from DLQI Scores
D1.295 - Clinical, Laboratory and Prognostic Evaluation of Antinuclear Antibody Positive and Negative Children with Chronic Urticaria
D1.298 - Topical gluconolactone induces immune tolerance in cutaneous lupus erythematosus in human and mice
D1.308 - Case report: challenges in a long-term prophylaxis in hereditary angioedema (HAE)
D1.310 - Phenotypes of patients with Hereditary Angioedema (HAE): a case series
D1.311 - Treatment Dilemmas in CARMIL2 Deficiency
D1.312 - Acquired C1-inhibitor deficiency angioedema treated with lanadelumab: a case series
D1.313 - Inborn Error of Immunity Associated Inflammatory Bowel Disease at a Tertiary Care Center
D1.315 - Classifying the unclassifiable: diagnosis, characterization, and management of adults with unclassified primary antibody deficiency (unPAD)
D1.316 - Lessons Learned from the Diagnosis and Management of a female pediatric patient with NCF2 Mutations and Chronic Granulomatous Disease
D1.317 - A Retrospective Analysis of Dengue-Associated Hemophagocytic Lymphohistiocytosis in a Dengue-Endemic Country
D1.318 - Extending Lanadelumab Dosing Intervals to Every 4 Weeks With Sustained Effectiveness for Hereditary Angioedema Attack Prevention: An Analysis From the Final ENABLE Study Data
D1.319 - The Silent Threat of Hereditary Angioedema in Children: Single Center Experience
D1.322 - A Prescription for Lower Immunity: The Hidden Cost of Certain Psychiatric Medications
Pagination
First page
First
Previous page
Previous
Page
1
Page
2
Current page
3
Page
4
Page
5
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download